Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: J Pain Symptom Manage. 2023 Feb 9;65(6):e715–e743. doi: 10.1016/j.jpainsymman.2023.02.003

Table 3.

Moderator Analyses

Moderator
(Model)
Outcome
QM(df), p
Moderator
Levels
LOR SE z 95% CI OR 95% CI
LB UB LB UB p
ACP Type (ME) Hospital Admission

QM(2) = 12.29, p = .002
Documentation components only −0.40 0.05 −8.21 −0.50 −0.31 0.67 0.61 0.74 <.001
Communication components only −0.91 0.14 −6.64 −1.18 −0.64 0.40 0.31 0.53 <.001
Full ACP −0.40 0.17 −2.34 −0.74 −0.07 0.67 0.48 0.94 .019
Study Design (FE with moderators) Hospice Use

QM(1) = 4.94, p = .026
Observational Study 0.42 0.15 2.86 0.13 0.71 1.52 1.14 2.03 .004
Experimental Study −0.11 0.18 −0.58 −0.48 0.26 0.90 0.62 1.29 .559

Abbreviations: ACP is advance care planning; FE is fixed effects; ME is mixed effects